Search for: "PFIZER"
Results 2561 - 2580
of 4,635
Sort by Relevance
|
Sort by Date
25 Aug 2011, 9:59 pm
In addition, the decision provides a contrast between how the Court views chemical obviousness for pharmaceutical formulations today, and the views contained in the Court's opinion in Pfizer, Inc. v. [read post]
25 Aug 2011, 12:59 am
Der Pharmakonzern Pfizer gelangte vor das Bundesgericht mit einer Beschwerde gegen die Ablehnung des Gesuchs, das von ihm hergestellte und von Swissmedic als Arzneimittel zugelassene Präparat „Champix“ zur Rauchentwöhnung bei Erwachsenen in die Spezialitätenliste (SL) aufzunehmen (vgl. [read post]
24 Aug 2011, 8:07 pm
Guest speakers include, Martha Riles, VP of IP Management, The Boeing Company and Barbara Dalton VP, Venture Capital, Pfizer. [read post]
24 Aug 2011, 12:33 am
General John LaMattian, former head of Pfizer R&D, says industry mergers have harmed R&D efforts (KEI) Non-communicable diseases and IP? [read post]
23 Aug 2011, 10:18 pm
A spokeswoman for Pfizer, Maureen McConnell, says that the study that was used by Health Canada did not link SSRIs or other antidepressants to a higher risks of PPHN. [read post]
19 Aug 2011, 9:23 am
Teva’s Lawsuit Against Viagra Patent Wilts Pfizer Inc. [read post]
16 Aug 2011, 11:53 am
Pfizer, ConocoPhilips, Lockeed Martin, Dow Chemical, etc… are on their board of directors). [read post]
16 Aug 2011, 10:31 am
There’s a Pfizer compound that hits JAK1/2/3 that’s already been through some Phase III work, a Novartis/Incyte compound that hits JAK1 and JAK2, which is now in Phase III, and a Lilly/Incyte compound that also hits JAK1 and JAK2 that’s in Phase II. [read post]
15 Aug 2011, 9:55 am
Pfizer Inc. [read post]
15 Aug 2011, 9:36 am
Joining Nicole to discuss practical guidance from those who have led the way on cost reduction initiatives are Ward Classen of CSC, my friend Susan Hackett of the newly formed Legal Executive Leadership, Margaret Madden from Pfizer, Justin Miller of DuPont and Lori Cohen of Greenberg Traurig. [read post]
15 Aug 2011, 7:32 am
The following is excerpted from an August 15, 2011 article by Phil Milford published by Bloomberg: Pfizer Inc. [read post]
12 Aug 2011, 8:30 am
Pfizer pays its domestic law firms largely through flat-fee arrangements. [read post]
11 Aug 2011, 3:15 am
The patent will expire later this year on Pfizer’s cholesterol-lowering drug Lipitor. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Relpax (Eletripian hydrobromide) – Pfizer settles Relpax infringement suit with Apotex (Patent Docs) Solodyn (Minocycline) – US: Medicis and Lupin settle Solodyn infringement dispute; Agree to drug development collaboration (Patent Docs) Viagra (Sildenafil citrate) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
9 Aug 2011, 4:30 am
Pfizer, 232 F.R.D. 360 (C.D. [read post]
8 Aug 2011, 12:53 pm
Violations of this act have led to multi-million dollar settlements with other pharmaceutical giants like Eli Lilly and Co. and Pfizer Inc. in the past. [read post]
6 Aug 2011, 11:53 am
Another 11 groups, including Pfizer Inc. [read post]
5 Aug 2011, 6:21 am
., Pfizer, Inc., Pharmacia Corporation and Pharmacia & Upjohn, LLC, Nabil Gazal sued the maker of Mirapex for breach of warranty and failure to warn after he developed a serious gambling problem he ascribed to treatment with Mirapex. [read post]
3 Aug 2011, 12:06 pm
(The case that the New York Times called his “crowning achievement” was a $2.3 billion settlement with Pfizer that was the result of a four-year secret investigation.) [read post]
3 Aug 2011, 5:11 am
Just north of Merck's Rahway site on US 1 is the now abandoned site of Exxon's Corporate Research Laboratory. 24/7WallSt , comparing Merck and Pfizer, discussed the patent issue: Differences between the two companies is most evident in the strategic measures the big pharma players seem to be taking to meet challenges arising from the expiration of key patents and the rise of generic competition.(...) [read post]
